1.
[Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus].
, , Polo Rodríguez, R, Galindo Puerto, MJ, Dueñas, C, Gómez Candela, C, Estrada, V, Villar, NG, Locutura, J, Mariño, A, Pascua, J, et al
Enfermedades infecciosas y microbiologia clinica. 2015;(1):40.e1-40.e16
Abstract
OBJECTIVE This consensus document is an update of metabolic disorders and cardiovascular risk (CVR) guidelines for HIV-infected patients. METHODS This document has been approved by an expert panel of GEAM, SPNS and GESIDA after reviewing the results of efficacy and safety of clinical trials, cohort and pharmacokinetic studies published in biomedical journals (PubMed and Embase) or presented in medical scientific meetings. Recommendation strength and the evidence in which they are supported are based on the GRADE system. RESULTS A healthy lifestyle is recommended, no smoking and at least 30min of aerobic exercise daily. In diabetic patients the same treatment as non-HIV infected patients is recommended. HIV patients with dyslipidemia should be considered as high CVR, thus its therapeutic objective is an LDL less than 100mg/dL. The antihypertensive of ACE inhibitors and ARAII families are better tolerated and have a lower risk of interactions. In HIV-patients with diabetes or metabolic syndrome and elevated transaminases with no defined etiology, the recommended is to rule out a hepatic steatosis Recommendations for action in hormone alterations are also updated. CONCLUSIONS These new guidelines update previous recommendations regarding all those metabolic disorders involved in CVR. Hormone changes and their management and the impact of metabolic disorders on the liver are also included.
2.
Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.
, , Polo Rodríguez, R, Galindo Puerto, MJ, Dueñas, C, Gómez Candela, C, Estrada, V, Villar, NG, Locutura, J, Mariño, A, Pascua, J, et al
Enfermedades infecciosas y microbiologia clinica. 2015;(1):41-7
Abstract
The importance of the metabolic disorders and their impact on patients with HIV infection requires an individualized study and continuous updating. HIV patients have the same cardiovascular risk factors as the general population. The HIV infection per se increases the cardiovascular risk, and metabolic disorders caused by some antiretroviral drugs are added risk factors. For this reason, the choice of drugs with a good metabolic profile is essential. The most common metabolic disorders of HIV infected-patients (insulin resistance, diabetes, hyperlipidemia or osteopenia), as well as other factors of cardiovascular risk, such as hypertension, should also be dealt with according to guidelines similar to the general population, as well as insisting on steps to healthier lifestyles. The aim of this document is to provide a query tool for all professionals who treat HIV-patients and who may present or display any metabolic disorders listed in this document.